SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-682583
Filing Date
2016-08-16
Accepted
2016-08-16 08:30:02
Documents
3
Period of Report
2016-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d146468d8k.htm 8-K 17516
2 EX-99.1 d146468dex991.htm EX-99.1 9707
3 GRAPHIC g146468snap1.jpg GRAPHIC 4288
  Complete submission text file 0001193125-16-682583.txt   34726
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 161834794
SIC: 2836 Biological Products, (No Diagnostic Substances)